Global Reach Seegene is a global molecular diagnostics leader with over 250 reagent kits and instruments sold worldwide, 8 overseas entities, and a revenue footprint outside Korea, presenting opportunities to expand regional partnerships, distribution, and service networks.

AMR Expansion Recent launches and pipeline in antimicrobial resistance testing such as the Allplex MDRO and MRSA assays indicate a growing portfolio in AMR diagnostics, offering cross-sell opportunities to current customers and entry points for new markets with high AMR prevalence.

Innovation Platform Movement toward a platform-based business with real time data analytics (STAgora) and automated workflows (CURECA) opens doors for enterprise collaborations, strategic integrations with LIS/PACS, and large-scale hospital or public health contracts.

Pandemic Legacy Seegene’s early COVID testing kits established credibility and a robust customer base; leverage this history to upsell advanced diagnostics, maintenance contracts, and higher-margin instruments to existing clients who trusted Seegene during the pandemic.

Quality and Scale With solides gross margins and a >$1B revenue profile, Seegene presents an attractive partner for large distributors and regionally focused labs seeking proven performance, enabling joint sales motions, co-marketing, and regional expansion deals.